Chinese Medical Journal · 2014 · 34 citations · 22 references
Fasudil ameliorates liver fibrosis in rats with type 2 diabetes at least partly by inhibiting TGFβ1/CTGF pathway and α-SMA expression. Inhibition of RhoA/ROCK may be a novel therapeutic target for liver fibrosis in diabetic non-alcoholic steatohepatitis.
22
RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease
Fang-Fang Peng, Dongcheng Wu, Bo Gao et al. · Diabetes · 2008 · 181 citations